stage of initial investment
Series A
year of initial investment
2022
location
Boston, Massachusetts
Visit Website
about
Novel tRNA therapeutics for genetics disorders
CEO
Daniel Fischer, CEO
Adipopharma
Back to list
Close light-box
X-Cor Therapeutics
AdipoPharma
Aluna
Angiocrine Bioscience
Aoa Diagnostics
Aralez Bio
Ateios
Avisi
Base Operations
Blue Ocean Gear
Boston Materials
Bounce Imaging
Cambridge Terahertz
Coagulo Medical Technologies
Coaptech
Coral Innovations
Databento
Dynepic
Eden GeoPower
Encora Therapeutics
Fermata
Fisherman
Fluree
Form Energy
Found Energy
GoPower EV
Hoofprint Biome
Interloop
Irys
Lemurian Labs
Leuko
Liminal
Lindy Biosciences
Nala Membranes
New Primal
NextPower360
Obsidio
OrbitFab
Osteoboost Health
Piction Health
Pienso
Pleural Dynamics
Pryon
Radia
Radical Plastics
Reflection Analytics
Relief Cardiovascular
Republic
ReviveMed
Rheos
Robigo
Skyhawk Therapeutics
Spectrohm
Spiro Robotics
SwiftSolar
Tevard Biosciences
Thiozen
Unison
VenoStent
X-Cor Therapeutics